Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesChange in TaxesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Agios Pharmaceuticals (AGIO) Shares Issued (2016 - 2025)

Historic Shares Issued for Agios Pharmaceuticals (AGIO) over the last 14 years, with Q3 2025 value amounting to $4.4 million.

  • Agios Pharmaceuticals' Shares Issued rose 6818.35% to $4.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $11.0 million, marking a year-over-year increase of 492.01%. This contributed to the annual value of $14.4 million for FY2024, which is 16582.0% up from last year.
  • According to the latest figures from Q3 2025, Agios Pharmaceuticals' Shares Issued is $4.4 million, which was up 6818.35% from $65000.0 recorded in Q2 2025.
  • Agios Pharmaceuticals' 5-year Shares Issued high stood at $25.7 million for Q2 2021, and its period low was $16000.0 during Q2 2022.
  • Its 5-year average for Shares Issued is $3.5 million, with a median of $1.6 million in 2025.
  • Its Shares Issued has fluctuated over the past 5 years, first skyrocketed by 145405.57% in 2021, then crashed by 9993.77% in 2022.
  • Quarter analysis of 5 years shows Agios Pharmaceuticals' Shares Issued stood at $267000.0 in 2021, then plummeted by 60.67% to $105000.0 in 2022, then surged by 706.67% to $847000.0 in 2023, then surged by 471.66% to $4.8 million in 2024, then decreased by 8.41% to $4.4 million in 2025.
  • Its Shares Issued was $4.4 million in Q3 2025, compared to $65000.0 in Q2 2025 and $1.6 million in Q1 2025.